US Stock MarketDetailed Quotes

Zevra Therapeutics (ZVRA)

Watchlist
  • 11.010
  • -0.650-5.57%
Close May 15 15:59 ET
  • 11.620
  • +0.610+5.54%
Post 18:56 ET
650.86MMarket Cap5.48P/E (TTM)

Zevra Therapeutics (ZVRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
77.54%36.22M
350.91%106.47M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.4M
-14.02%23.61M
-6.79%12.04M
27.63%3.7M
-47.47%4.45M
Operating revenue
77.54%36.22M
350.91%106.47M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.4M
-14.02%23.61M
-6.79%12.04M
27.63%3.7M
-47.47%4.45M
Cost of revenue
41.04%1.9M
122.22%16.48M
11.27%1.52M
-46.24%1.24M
246.46%12.38M
668.57%1.35M
241.33%7.42M
11.33%1.37M
1,499.31%2.3M
427.77%3.57M
Gross profit
80.12%34.32M
455.65%89.99M
205.38%32.61M
1,683.41%24.83M
1,441.32%13.5M
486.34%19.06M
-35.96%16.2M
-8.69%10.68M
-49.40%1.39M
-88.76%876K
Operating expense
4.39%25.49M
-8.70%94.22M
-10.74%23.29M
-27.93%20.68M
4.70%25.83M
2.87%24.42M
37.80%103.2M
-2.82%26.09M
58.42%28.7M
75.66%24.67M
Selling and administrative expenses
6.33%20.78M
41.46%77.62M
26.23%20.35M
4.49%16.94M
64.88%20.78M
96.81%19.55M
59.90%54.87M
10.02%16.13M
178.58%16.21M
90.62%12.6M
Research and development costs
34.81%4.39M
-69.73%12.74M
-68.63%2.62M
-68.64%3.43M
-67.37%3.43M
-73.46%3.26M
5.75%42.1M
-26.87%8.35M
-10.99%10.95M
41.54%10.52M
Depreciation amortization depletion
-80.43%316K
-38.06%3.86M
-80.45%316K
-79.61%315K
4.53%1.62M
5.69%1.62M
707.64%6.24M
109.33%1.62M
--1.55M
--1.55M
-Depreciation and amortization
-80.43%316K
-38.06%3.86M
-80.45%316K
-79.61%315K
4.53%1.62M
5.69%1.62M
707.64%6.24M
109.33%1.62M
--1.55M
--1.55M
Operating profit
264.71%8.83M
95.13%-4.23M
160.42%9.32M
115.17%4.14M
48.19%-12.33M
73.83%-5.36M
-75.40%-87M
-1.71%-15.42M
-77.73%-27.31M
-280.60%-23.8M
Net non-operating interest income expense
231.70%1.88M
80.08%-1.03M
89.59%-236K
120.74%262K
120.05%369K
-835.05%-1.43M
-270.26%-5.18M
-315.20%-2.27M
-192.06%-1.26M
-235.69%-1.84M
Non-operating interest income
560.96%3.59M
219.36%6.95M
2,445.21%1.71M
120.50%2.31M
780.74%2.38M
-41.55%543K
-52.10%2.18M
-134.76%-73K
-39.64%1.05M
-82.61%270K
Non-operating interest expense
-13.10%1.71M
8.52%7.98M
-11.21%1.95M
-11.29%2.05M
-4.79%2.01M
167.89%1.97M
389.74%7.35M
190.21%2.19M
531.69%2.31M
971.07%2.11M
Other net income (expense)
599.94%34.09M
4,409.17%91.94M
233.59%3.59M
-15.59%-5.38M
1,437.47%88.87M
35.31%4.87M
295.92%2.04M
35.90%-2.69M
-222.46%-4.66M
157.00%5.78M
Gain on sale of security
-232.70%-6.46M
14.12%2.33M
233.59%3.59M
-15.59%-5.38M
-112.96%-749K
35.31%4.87M
295.92%2.04M
35.90%-2.69M
-222.46%-4.66M
157.00%5.78M
Special income (charges)
--40.56M
--89.62M
--0
--0
--89.62M
--0
--0
--0
--0
--0
-Less:Impairment of capital assets
----
--58.71M
--0
--0
--58.71M
----
--0
--0
--0
--0
-Less:Other special charges
--2.76M
----
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
--43.31M
--148.33M
--0
--0
--148.33M
----
--0
--0
--0
--0
Income before tax
2,437.19%44.8M
196.16%86.68M
162.19%12.67M
97.06%-977K
487.34%76.91M
88.52%-1.92M
-95.75%-90.14M
-2.39%-20.37M
-226.05%-33.23M
-650.09%-19.86M
Income tax
484.94%6.91M
-77.56%3.45M
-96.74%501K
-433K
3,041.43%2.2M
1,788.57%1.18M
15.37M
15.37M
0
194.59%70K
Net income
1,322.65%37.89M
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
Net income continuous Operations
1,322.65%37.89M
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
Minority interest income
Net income attributable to the parent company
1,322.65%37.89M
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,322.65%37.89M
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
Basic earnings per share
1,133.33%0.62
161.40%1.4
128.99%0.2
98.55%-0.01
358.33%1.24
85.00%-0.06
-75.38%-2.28
-27.78%-0.69
-130.00%-0.69
-500.00%-0.48
Diluted earnings per share
1,100.00%0.6
159.21%1.35
127.54%0.19
98.55%-0.01
352.08%1.21
85.00%-0.06
-75.38%-2.28
-27.78%-0.69
-130.00%-0.69
-500.00%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 77.54%36.22M350.91%106.47M183.36%34.13M605.36%26.06M481.73%25.88M495.65%20.4M-14.02%23.61M-6.79%12.04M27.63%3.7M-47.47%4.45M
Operating revenue 77.54%36.22M350.91%106.47M183.36%34.13M605.36%26.06M481.73%25.88M495.65%20.4M-14.02%23.61M-6.79%12.04M27.63%3.7M-47.47%4.45M
Cost of revenue 41.04%1.9M122.22%16.48M11.27%1.52M-46.24%1.24M246.46%12.38M668.57%1.35M241.33%7.42M11.33%1.37M1,499.31%2.3M427.77%3.57M
Gross profit 80.12%34.32M455.65%89.99M205.38%32.61M1,683.41%24.83M1,441.32%13.5M486.34%19.06M-35.96%16.2M-8.69%10.68M-49.40%1.39M-88.76%876K
Operating expense 4.39%25.49M-8.70%94.22M-10.74%23.29M-27.93%20.68M4.70%25.83M2.87%24.42M37.80%103.2M-2.82%26.09M58.42%28.7M75.66%24.67M
Selling and administrative expenses 6.33%20.78M41.46%77.62M26.23%20.35M4.49%16.94M64.88%20.78M96.81%19.55M59.90%54.87M10.02%16.13M178.58%16.21M90.62%12.6M
Research and development costs 34.81%4.39M-69.73%12.74M-68.63%2.62M-68.64%3.43M-67.37%3.43M-73.46%3.26M5.75%42.1M-26.87%8.35M-10.99%10.95M41.54%10.52M
Depreciation amortization depletion -80.43%316K-38.06%3.86M-80.45%316K-79.61%315K4.53%1.62M5.69%1.62M707.64%6.24M109.33%1.62M--1.55M--1.55M
-Depreciation and amortization -80.43%316K-38.06%3.86M-80.45%316K-79.61%315K4.53%1.62M5.69%1.62M707.64%6.24M109.33%1.62M--1.55M--1.55M
Operating profit 264.71%8.83M95.13%-4.23M160.42%9.32M115.17%4.14M48.19%-12.33M73.83%-5.36M-75.40%-87M-1.71%-15.42M-77.73%-27.31M-280.60%-23.8M
Net non-operating interest income expense 231.70%1.88M80.08%-1.03M89.59%-236K120.74%262K120.05%369K-835.05%-1.43M-270.26%-5.18M-315.20%-2.27M-192.06%-1.26M-235.69%-1.84M
Non-operating interest income 560.96%3.59M219.36%6.95M2,445.21%1.71M120.50%2.31M780.74%2.38M-41.55%543K-52.10%2.18M-134.76%-73K-39.64%1.05M-82.61%270K
Non-operating interest expense -13.10%1.71M8.52%7.98M-11.21%1.95M-11.29%2.05M-4.79%2.01M167.89%1.97M389.74%7.35M190.21%2.19M531.69%2.31M971.07%2.11M
Other net income (expense) 599.94%34.09M4,409.17%91.94M233.59%3.59M-15.59%-5.38M1,437.47%88.87M35.31%4.87M295.92%2.04M35.90%-2.69M-222.46%-4.66M157.00%5.78M
Gain on sale of security -232.70%-6.46M14.12%2.33M233.59%3.59M-15.59%-5.38M-112.96%-749K35.31%4.87M295.92%2.04M35.90%-2.69M-222.46%-4.66M157.00%5.78M
Special income (charges) --40.56M--89.62M--0--0--89.62M--0--0--0--0--0
-Less:Impairment of capital assets ------58.71M--0--0--58.71M------0--0--0--0
-Less:Other special charges --2.76M------------------------------------
-Gain on sale of property,plant,equipment --43.31M--148.33M--0--0--148.33M------0--0--0--0
Income before tax 2,437.19%44.8M196.16%86.68M162.19%12.67M97.06%-977K487.34%76.91M88.52%-1.92M-95.75%-90.14M-2.39%-20.37M-226.05%-33.23M-650.09%-19.86M
Income tax 484.94%6.91M-77.56%3.45M-96.74%501K-433K3,041.43%2.2M1,788.57%1.18M15.37M15.37M0194.59%70K
Net income 1,322.65%37.89M178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M
Net income continuous Operations 1,322.65%37.89M178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M
Minority interest income
Net income attributable to the parent company 1,322.65%37.89M178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,322.65%37.89M178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M
Basic earnings per share 1,133.33%0.62161.40%1.4128.99%0.298.55%-0.01358.33%1.2485.00%-0.06-75.38%-2.28-27.78%-0.69-130.00%-0.69-500.00%-0.48
Diluted earnings per share 1,100.00%0.6159.21%1.35127.54%0.1998.55%-0.01352.08%1.2185.00%-0.06-75.38%-2.28-27.78%-0.69-130.00%-0.69-500.00%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More